Literature DB >> 18563374

[In-vivo diagnosis of malignant hyperthermia susceptibility: a microdialysis study].

F Schuster1, M Hager, T Metterlein, R M Muellenbach, T Wurmb, C Wunder, N Roewer, M Anetseder.   

Abstract

BACKGROUND: In malignant hyperthermia (MH), volatile anesthetics induce hypermetabolism, lactic acidosis and rhabdomyolysis in predisposed patients. The authors hypothesized that intramuscular caffeine and halothane application would increase local lactate concentration in MH susceptible (MHS) individuals more than in non-susceptible (MHN) subjects without initiating the full MH syndrome.
METHODS: In 14 MHS, 12 MHN and 7 control individuals, microdialysis probes were placed in the rectus femoris muscle and perfused with Ringer's solution at 1 microl/min. After equilibration, 250 microl caffeine (80 mM) was injected through the first microdialysis probe, halothane 10 vol% dissolved in soybean oil was perfused through a second microdialysis probe and a third probe was used for control measurements. Dialysate samples were analyzed for lactate spectrophotometrically. Systemic hemodynamic and metabolic parameters were measured. Data are presented as median and quartiles.
RESULTS: Intramuscular caffeine and halothane significantly increased local peak concentrations of lactate in MHS probands [5.0 mM (3.4-8.1 mM) and 3.7 mM (2.6-5.0 mM), respectively] compared to MHN [1.6 mM (1.3-2.0 mM) and 1.9 mM (1.6-2.0 mM)] or control individuals [2.1 mM (1.9-2.3 mM) and 2.0 mM (1.6-2.1 mM)]. This was accompanied by a higher serum creatine kinase level in the MHS group. Hemodynamic and metabolic parameters were normal in the investigated groups.
CONCLUSION: Intramuscular caffeine and halothane application induces a temporary and abnormal increase of local lactate in MHS individuals. No serious systemic side effects occurred. This study presents evidence that metabolic monitoring with local stimulation by caffeine and halothane may allow a minimally invasive diagnosis of MH susceptibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563374     DOI: 10.1007/s00101-008-1399-6

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  14 in total

1.  Serum myoglobin and creatine kinase following surgery.

Authors:  A S Laurence
Journal:  Br J Anaesth       Date:  2000-06       Impact factor: 9.166

Review 2.  A breakthrough in the genetic diagnosis of malignant hyperthermia.

Authors:  R L Robinson; P M Hopkins
Journal:  Br J Anaesth       Date:  2001-02       Impact factor: 9.166

Review 3.  Microdialysis--theory and application.

Authors:  H Benveniste; P C Hüttemeier
Journal:  Prog Neurobiol       Date:  1990       Impact factor: 11.685

4.  Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.

Authors:  Saiid Bina; George Cowan; John Karaian; Sheila Muldoon; Paul Mongan; Rolf Bünger
Journal:  Anesthesiology       Date:  2006-01       Impact factor: 7.892

Review 5.  Mutations in RYR1 in malignant hyperthermia and central core disease.

Authors:  Rachel Robinson; Danielle Carpenter; Marie-Anne Shaw; Jane Halsall; Philip Hopkins
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

6.  The anesthetic and physiologic effects of an intravenous administration of a halothane lipid emulsion (5% vol/vol)

Authors:  J B Musser; J L Fontana; P D Mongan
Journal:  Anesth Analg       Date:  1999-03       Impact factor: 5.108

7.  Intramuscular injection of sevoflurane detects malignant hyperthermia predisposition in susceptible pigs.

Authors:  Frank Schuster; Thomas Metterlein; Sabrina Negele; Annegret Gardill; Ulrich Schwemmer; Norbert Roewer; Martin Anetseder
Journal:  Anesthesiology       Date:  2007-10       Impact factor: 7.892

8.  A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.

Authors: 
Journal:  Br J Anaesth       Date:  1984-11       Impact factor: 9.166

9.  [Fulminant MH crisis during the ninth general anaesthesia].

Authors:  Horst Adam; Udo Gottschaldt; Niels C Pausch; Henrik Rüffert; Kai M Sipli
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2007-10       Impact factor: 0.698

Review 10.  Microdialysis--principles and applications for studies in animals and man.

Authors:  U Ungerstedt
Journal:  J Intern Med       Date:  1991-10       Impact factor: 8.989

View more
  2 in total

Review 1.  [Malignant hyperthermia].

Authors:  T Metterlein; F Schuster; B M Graf; M Anetseder
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

2.  Metabolic effects as a cause of myotoxic effects of fluoroquinolones.

Authors:  Thomas Metterlein; Frank Schuster; Martin Hager; Norbert Roewer; Martin Anetseder
Journal:  Indian J Pharmacol       Date:  2015 Nov-Dec       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.